MX2022006312A - Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos. - Google Patents

Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.

Info

Publication number
MX2022006312A
MX2022006312A MX2022006312A MX2022006312A MX2022006312A MX 2022006312 A MX2022006312 A MX 2022006312A MX 2022006312 A MX2022006312 A MX 2022006312A MX 2022006312 A MX2022006312 A MX 2022006312A MX 2022006312 A MX2022006312 A MX 2022006312A
Authority
MX
Mexico
Prior art keywords
ahr inhibitors
ahr
inhibitors
formulations
methods
Prior art date
Application number
MX2022006312A
Other languages
English (en)
Spanish (es)
Inventor
Alfredo C Castro
Iii James Martin Nolan
Xiaoyan Michelle Zhang
Jason Sager
Original Assignee
Ikena Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ikena Oncology Inc filed Critical Ikena Oncology Inc
Publication of MX2022006312A publication Critical patent/MX2022006312A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2022006312A 2019-11-26 2020-11-25 Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos. MX2022006312A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962940514P 2019-11-26 2019-11-26
US202063106530P 2020-10-28 2020-10-28
PCT/US2020/062116 WO2021108469A1 (en) 2019-11-26 2020-11-25 Ahr inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
MX2022006312A true MX2022006312A (es) 2022-06-22

Family

ID=73856333

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006312A MX2022006312A (es) 2019-11-26 2020-11-25 Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.

Country Status (11)

Country Link
US (1) US20230026232A1 (https=)
EP (1) EP4065090A1 (https=)
JP (1) JP2023503167A (https=)
KR (1) KR20220125232A (https=)
CN (1) CN115279347A (https=)
AU (1) AU2020391451A1 (https=)
BR (1) BR112022010143A2 (https=)
CA (1) CA3159315A1 (https=)
IL (1) IL293325A (https=)
MX (1) MX2022006312A (https=)
WO (1) WO2021108469A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
AU2020394424A1 (en) 2019-11-26 2022-06-16 Ikena Oncology, Inc. Polymorphic carbazole derivatives and uses thereof
US12570638B2 (en) 2020-05-20 2026-03-10 Sail Biomedicines, Inc. Fused imidazole derivatives as AHR antagonists
CN119768155A (zh) * 2022-09-14 2025-04-04 艾库斯生物科学有限公司 依曲地南的分散体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103837D0 (en) * 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
MX2019012431A (es) * 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
EP3774767B1 (en) * 2018-04-05 2025-10-29 Beth Israel Deaconess Medical Center, Inc. Aryl hydrocarbon receptor modulators and uses thereof
US20220185795A1 (en) * 2019-03-11 2022-06-16 Ptc Therapeutics, Inc. Compound form having enhanced bioavailability and formulations thereof

Also Published As

Publication number Publication date
IL293325A (en) 2022-07-01
BR112022010143A2 (pt) 2022-08-09
US20230026232A1 (en) 2023-01-26
WO2021108469A1 (en) 2021-06-03
CN115279347A (zh) 2022-11-01
AU2020391451A1 (en) 2022-06-16
EP4065090A1 (en) 2022-10-05
CA3159315A1 (en) 2021-06-03
KR20220125232A (ko) 2022-09-14
JP2023503167A (ja) 2023-01-26

Similar Documents

Publication Publication Date Title
MX2021014441A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
MY208549A (en) Parp1 inhibitors
ZA201906822B (en) Indole ahr inhibitors and uses thereof
MX2021004245A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
MY205416A (en) Tyk2 inhibitors and uses thereof
MX2023009527A (es) Degradadores de la cinasa 4 asociada al receptor de interleucina 1 (irak4) y usos de los mismos.
PH12021552856A1 (en) Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
WO2020243415A3 (en) Tead inhibitors and uses thereof
MX2025003987A (es) Antagonistas de cinasa progenitora hematopoyetica 1 (hpk1) y sus usos
MX2020007797A (es) Inhibidores de la cinasa 2 de control general no desrepresible (gcn2) y usos de los mismos.
EP3848370A3 (en) Tyk2 inhibitors and uses thereof
PH12022550469A1 (en) Kras g12d inhibitors
PH12022551522A1 (en) Smarca degraders and uses thereof
PH12020550622A1 (en) Kras g12c inhibitors
PH12021553018A1 (en) New egfr inhibitors
GEP20237506B (en) Pcsk9 antagonist compounds
MX2022004304A (es) Agentes inductores de apoptosis.
MX2020001793A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
EP4327809A3 (en) Tyk2 inhibitors and uses thereof
MX2025006196A (es) Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso
JOP20180039A1 (ar) مثبطات pd-1/pd-l1
GEP20227443B (en) Magl inhibitors
MX2025010681A (es) Formulaciones transdermicas
MX2022006312A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
MX2025015277A (es) Inhibidores de masp-2 y metodos de uso